{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:05:22Z","timestamp":1792134322773,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR- PE06_SPOKE 4 (CUP B53C22004000006)"],"award-info":[{"award-number":["PNRR- PE06_SPOKE 4 (CUP B53C22004000006)"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-12269-7","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:23:04Z","timestamp":1770967384000},"page":"5690-5700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Artificial intelligence-assisted reading of non-contrast prostate MRI: application and concordance with expert interpretation in a screening population within the PROSA trial"],"prefix":"10.1007","volume":"36","author":[{"given":"Emanuele","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mezzapesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Laschena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lucciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Landini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sciarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3091-8192","authenticated-orcid":false,"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"12269_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"12269_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.eururo.2020.12.010","volume":"79","author":"H Van Poppel","year":"2021","unstructured":"Van Poppel H, Hogenhout R, Albers P, van den Bergh R, Barentsz JO, Roobol MJ (2021) Early detection of prostate cancer in 2020 and beyond: facts and recommendations for the European Union and the European Commission. Eur Urol 79:327\u2013329. https:\/\/doi.org\/10.1016\/j.eururo.2020.12.010","journal-title":"Eur Urol"},{"key":"12269_CR3","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","volume":"384","author":"FH Schr\u00f6der","year":"2014","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384:2027\u20132035. https:\/\/doi.org\/10.1016\/S0140-6736(14)60525-0","journal-title":"Lancet"},{"key":"12269_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","volume":"76","author":"J Hugosson","year":"2019","unstructured":"Hugosson J, Roobol MJ, M\u00e5nsson M et al (2019) A 16-yr follow-up of the European randomized study of screening for prostate cancer. Eur Urol 76:43\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.009","journal-title":"Eur Urol"},{"key":"12269_CR5","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767\u20131777. https:\/\/doi.org\/10.1056\/NEJMoa1801993","journal-title":"N Engl J Med"},{"key":"12269_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Puech P, Renard-Penna R et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100\u2013109. https:\/\/doi.org\/10.1016\/S1470-2045(18)30569-2","journal-title":"Lancet Oncol"},{"key":"12269_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"M van der Leest","year":"2019","unstructured":"van der Leest M, Cornel E, Isra\u00ebl B et al (2019) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonanceguided biopsy in biopsy-na\u00efve men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol 75:570\u2013578. https:\/\/doi.org\/10.1016\/j.eururo.2018.11.023","journal-title":"Eur Urol"},{"key":"12269_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cct.2015.02.008","volume":"42","author":"A El-Shater Bosaily","year":"2015","unstructured":"El-Shater Bosaily A, Parker C, Brown LC et al (2015) PROMIS\u2014prostate MR imaging study: a paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer. Contemp Clin Trials 42:26\u201340. https:\/\/doi.org\/10.1016\/j.cct.2015.02.008","journal-title":"Contemp Clin Trials"},{"key":"12269_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","volume":"77","author":"FH Drost","year":"2020","unstructured":"Drost FH, Osses D, Nieboer D et al (2020) Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis. Eur Urol 77:78\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2019.06.023","journal-title":"Eur Urol"},{"key":"12269_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2214\/AJR.20.24268","volume":"216","author":"IG Schoots","year":"2021","unstructured":"Schoots IG, Barentsz JO, Bittencourt LK et al (2021) PI-RADS committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review. AJR Am J Roentgenol 216:3\u201319. https:\/\/doi.org\/10.2214\/AJR.20.24268","journal-title":"AJR Am J Roentgenol"},{"key":"12269_CR11","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1007\/s00330-023-09605-0","volume":"33","author":"E Messina","year":"2023","unstructured":"Messina E, Pecoraro M, Laschena L et al (2023) Low cancer yield in PIRADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: Is it time to reconsider scoring categorization? Eur Radiol 33:5828\u20135839. https:\/\/doi.org\/10.1007\/s00330-023-09605-0","journal-title":"Eur Radiol"},{"key":"12269_CR12","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1007\/s00330-019-06654-2","volume":"30","author":"G Brembilla","year":"2020","unstructured":"Brembilla G, Dell'oglio P, Stabile A et al (2020) Interreader variability in prostate MRI reporting using prostate imaging reporting and data system version 2.1. Eur Radiol 30:3383\u20133392. https:\/\/doi.org\/10.1007\/s00330-019-06654-2","journal-title":"Eur Radiol"},{"key":"12269_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340\u2013351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"key":"12269_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1148\/radiol.212252","volume":"304","author":"M Pecoraro","year":"2022","unstructured":"Pecoraro M, Turkbey B, Purysko AS et al (2022) Diagnostic accuracy and observer agreement of the MRI prostate imaging for recurrence reporting assessment score. Radiology 304:342\u2013350. https:\/\/doi.org\/10.1148\/radiol.212252","journal-title":"Radiology"},{"key":"12269_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","volume":"25","author":"A Saha","year":"2024","unstructured":"Saha A, Bosma JS, Twilt JJ et al (2024) Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol 25:879\u2013887. https:\/\/doi.org\/10.1016\/S1470-2045(24)00220-1","journal-title":"Lancet Oncol"},{"key":"12269_CR16","doi-asserted-by":"publisher","first-page":"e222276","DOI":"10.1148\/radiol.222276","volume":"307","author":"CA Hamm","year":"2023","unstructured":"Hamm CA, Baumg\u00e4rtner GL, Biessmann F et al (2023) Interactive explainable deep learning model informs prostate cancer diagnosis at MRI. Radiology 307:e222276. https:\/\/doi.org\/10.1148\/radiol.222276","journal-title":"Radiology"},{"key":"12269_CR17","doi-asserted-by":"publisher","first-page":"9567","DOI":"10.1007\/s00330-021-08021-6","volume":"31","author":"T Penzkofer","year":"2021","unstructured":"Penzkofer T, Padhani AR, Turkbey B et al (2021) ESUR\/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging. Eur Radiol 31:9567\u20139578. https:\/\/doi.org\/10.1007\/s00330-021-08021-6","journal-title":"Eur Radiol"},{"key":"12269_CR18","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1007\/s00330-023-09433-2","volume":"33","author":"G Liu","year":"2023","unstructured":"Liu G, Pan S, Zhao R et al (2023) The added value of AI-based computeraided diagnosis in classification of cancer at prostate MRI. Eur Radiol 33:5118\u20135130. https:\/\/doi.org\/10.1007\/s00330-023-09433-2","journal-title":"Eur Radiol"},{"key":"12269_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s11547-022-01555-9","volume":"127","author":"S Cipollari","year":"2022","unstructured":"Cipollari S, Pecoraro M, Forookhi A et al (2022) Biparametric prostate MRI: impact of a deep learning-based software and of quantitative ADC values on the inter-reader agreement of experienced and inexperienced readers. Radiol Med 127:1245\u20131253. https:\/\/doi.org\/10.1007\/s11547-022-01555-9","journal-title":"Radiol Med"},{"key":"12269_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00330-023-10019-1","volume":"34","author":"E Messina","year":"2023","unstructured":"Messina E, La Torre G, Pecoraro M et al (2023) Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial\u2014prostate cancer secondary screening in Sapienza (PROSA). Eur Radiol 34:204\u2013213. https:\/\/doi.org\/10.1007\/s00330-023-10019-1","journal-title":"Eur Radiol"},{"key":"12269_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.eururo.2018.05.035","volume":"75","author":"AR Padhani","year":"2019","unstructured":"Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J (2019) Prostate imagingreporting and data system steering committee: PI-RADS v2 status update and future directions. Eur Urol 75:385\u2013396. https:\/\/doi.org\/10.1016\/j.eururo.2018.05.035","journal-title":"Eur Urol"},{"key":"12269_CR22","doi-asserted-by":"publisher","first-page":"20210528","DOI":"10.1259\/bjr.20210528","volume":"95","author":"M Del Monte","year":"2022","unstructured":"Del Monte M, Cipollari S, Del Giudice F et al (2022) MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI in-bore vs MRI-transrectal ultrasound fusion-targeted techniques. Br J Radiol 95:20210528. https:\/\/doi.org\/10.1259\/bjr.20210528","journal-title":"Br J Radiol"},{"key":"12269_CR23","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","volume":"30","author":"M De Rooij","year":"2020","unstructured":"De Rooij M, Isra\u00ebl B, Tummers M et al (2020) ESUR\/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists\u2019 training. Eur Radiol 30:5404\u20135416. https:\/\/doi.org\/10.1007\/s00330-020-06929-z","journal-title":"Eur Radiol"},{"key":"12269_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","volume":"3","author":"F Giganti","year":"2020","unstructured":"Giganti F, Allen C, Emberton M, Moore CM, Kasivisvanathan V, PRECISION study g (2020) Prostate imaging quality (PIQUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial. Eur Urol Oncol 3:615\u2013619. https:\/\/doi.org\/10.1016\/j.euo.2020.06.007","journal-title":"Eur Urol Oncol"},{"key":"12269_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jmri.27879","volume":"55","author":"S Cipollari","year":"2022","unstructured":"Cipollari S, Guarrasi V, Pecoraro M et al (2022) Convolutional neural networks for automated classification of prostate multiparametric magnetic resonance imaging based on image quality. J Magn Reson Imaging Imaging 55:480\u2013490. https:\/\/doi.org\/10.1002\/jmri.27879","journal-title":"J Magn Reson Imaging"},{"key":"12269_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.euo.2023.05.008","volume":"7","author":"M Pecoraro","year":"2023","unstructured":"Pecoraro M, Catanzaro G, Conte F et al (2023) Prospective validation study of a novel integrated pathway based on clinical features, magnetic resonance imaging biomarkers, and MicroRNAs for early detection of prostate cancer. Eur Urol Oncol 7:73\u201382. https:\/\/doi.org\/10.1016\/j.euo.2023.05.008","journal-title":"Eur Urol Oncol"},{"key":"12269_CR27","doi-asserted-by":"publisher","first-page":"e0322925","DOI":"10.1371\/journal.pone.0322925","volume":"20","author":"MT Ramli Hamid","year":"2025","unstructured":"Ramli Hamid MT, Ab Mumin N, Abdul Hamid S et al (2025) Comparative analysis of diagnostic performance in mammography: a reader study on the impact of AI assistance. PLoS One 20:e0322925. https:\/\/doi.org\/10.1371\/journal.pone.0322925","journal-title":"PLoS One"},{"key":"12269_CR28","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1007\/s00330-020-07545-7","volume":"31","author":"V Bura","year":"2021","unstructured":"Bura V, Caglic I, Snoj Z et al (2021) MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences. Eur Radiol 31:4908\u20134917. https:\/\/doi.org\/10.1007\/s00330-020-07545-7","journal-title":"Eur Radiol"},{"key":"12269_CR29","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/j.1464-410X.2012.11469.x","volume":"110","author":"B Turkbey","year":"2012","unstructured":"Turkbey B, Huang R, Vourganti S et al (2012) Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int 110:1642\u20131647. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11469.x","journal-title":"BJU Int"},{"key":"12269_CR30","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/j.1464-410X.2012.11146.x","volume":"110","author":"A Sciarra","year":"2012","unstructured":"Sciarra A, Panebianco V, Cattarino S et al (2012) Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy. BJU Int 110:1661\u20131665. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11146.x","journal-title":"BJU Int"},{"key":"12269_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21037\/tau.2017.12.31","volume":"7","author":"IG Schoots","year":"2018","unstructured":"Schoots IG (2018) MRI in early prostate cancer detection: How to manage indeterminate or equivocal PI-RADS 3 lesions? Transl Androl Urol 7:70\u201382. https:\/\/doi.org\/10.21037\/tau.2017.12.31","journal-title":"Transl Androl Urol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12269-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-12269-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12269-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:17:55Z","timestamp":1781864275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-12269-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["12269"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-12269-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Valeria Panebianco.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"V.P. is a member of the Scientific Editorial Board of European Radiology (section: Urogenital) and, as such, did not participate in the selection or review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Some study subjects or cohorts have been previously reported in a European Radiology publication (doi: 10.1007\/s00330-023-10019-1).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}